Skip to main content

Insight Molecular Diagnostics Inc.

IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001642380

No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Insight Molecular Diagnostics Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
59
−4 vs. Q3 2022
Shares held
60.8M
−5.04M (−7.7%) vs. Q3 2022
Total value
$19.5M
−$28.5M (−59.4%) vs. Q3 2022
New holders
9
10 more added
Sold out
13
20 more reduced

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IMDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 59 institutions
Q1 2021: 87 institutionsQ2 2021: 91 institutionsQ3 2021: 95 institutionsQ4 2021: 89 institutionsQ1 2022: 86 institutionsQ2 2022: 76 institutionsQ3 2022: 65 institutionsQ4 2022: 59 institutionsQ1 2023: 52 institutionsQ2 2023: 47 institutionsQ3 2023: 30 institutionsQ4 2023: 26 institutionsQ1 2024: 25 institutionsQ2 2024: 23 institutionsQ3 2024: 21 institutionsQ4 2024: 27 institutionsQ1 2025: 30 institutionsQ2 2025: 30 institutionsQ3 2025: 27 institutionsQ4 2025: 35 institutionsQ1 2026: 41 institutionsQ2 2026: 40 institutions
Value heldQ4 2022: $19.5M
Q1 2021: $283.0MQ2 2021: $324.6MQ3 2021: $201.9MQ4 2021: $120.1MQ1 2022: $81.1MQ2 2022: $61.8MQ3 2022: $48.3MQ4 2022: $19.5MQ1 2023: $19.7MQ2 2023: $21.1MQ3 2023: $14.3MQ4 2023: $11.1MQ1 2024: $12.8MQ2 2024: $21.1MQ3 2024: $20.4MQ4 2024: $20.0MQ1 2025: $49.2MQ2 2025: $48.9MQ3 2025: $54.1MQ4 2025: $124.9MQ1 2026: $62.1MQ2 2026: $108.9M
Institutions holding IMDX and their total value by quarter
QuarterHoldersValue
Q2 202640$108.9M
Q1 202641$62.1M
Q4 202535$124.9M
Q3 202527$54.1M
Q2 202530$48.9M
Q1 202530$49.2M
Q4 202427$20.0M
Q3 202421$20.4M
Q2 202423$21.1M
Q1 202425$12.8M
Q4 202326$11.1M
Q3 202330$14.3M
Q2 202347$21.1M
Q1 202352$19.7M
Q4 202259$19.5M
Q3 202265$48.3M
Q2 202276$61.8M
Q1 202286$81.1M
Q4 202189$120.1M
Q3 202195$201.9M
Q2 202191$324.6M
Q1 202187$283.0M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Insight Molecular Diagnostics Inc.; share changes are against Q3 2022.

Institutions holding IMDX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Broadwood Capital Inc23,353,697$7.49M0.63%00.0%Unchanged
Pura Vida Investments, LLC18,056,274$5.79M0.97%00.0%Unchanged
AWM Investment Company, Inc.7,254,222$2.33M0.34%−492,335−6.4%Reduced
Vanguard Group Inc4,359,202$1.40M0.00%+2,500+0.1%Added
Defender Capital, LLC.2,272,930$729.4K0.29%−279,050−10.9%Reduced
BlackRock Inc.1,418,408$455.2K0.00%−886,923−38.5%Reduced
Geode Capital Management, LLC992,454$318.0K0.00%−2,500−0.3%Reduced
Millennium Management LLC561,361$180.0K0.00%−160,025−22.2%Reduced
Schonfeld Strategic Advisors LLC423,900$136.0K0.00%−325,800−43.5%Reduced
State Street Corp281,845$90.4K0.00%00.0%Unchanged
Northern Trust Corp208,799$67.0K0.00%00.0%Unchanged
Penbrook Management LLC207,675$66.6K0.06%−355,675−63.1%Reduced
Bridgeway Capital Management, LLC205,300$65.9K0.00%00.0%Unchanged
LPL Financial LLC141,025$45.3K0.00%+2,184+1.6%Added
Ergoteles LLC102,756$33.0K0.00%+38,454+59.8%Added
Deutsche Bank AG67,670$21.7K0.00%00.0%Unchanged
Susquehanna International Group, LLP65,592$21.0K0.00%+65,592New
Bank of New York Mellon Corp63,107$20.3K0.00%−163−0.3%Reduced
Charles Schwab Investment Management Inc62,284$20.0K0.00%00.0%Unchanged
Goldman Sachs Group Inc61,548$19.8K0.00%−319,984−83.9%Reduced
Morgan Stanley44,044$14.1K0.00%−65,299−59.7%Reduced
Ameriprise Financial Inc42,900$14.0K0.00%−3,000−6.5%Reduced
Jane Street Group, LLC42,068$13.5K0.00%+11,346+36.9%Added
Wealth Effects LLC40,500$13.0K0.01%−10,500−20.6%Reduced
Bank of America Corp40,394$12.9K0.00%−22,809−36.1%Reduced
Tri Locum Partners LP38,847$12.0K0.01%+38,847New
UBS Group AG36,814$11.8K0.00%+11,239+43.9%Added
Merit Financial Group, LLC32,000$10.3K0.00%+32,000New
Lee Danner & Bass Inc27,763$9.00K0.00%+27,763New
Renaissance Technologies LLC28,200$9.00K0.00%+28,200New
Advisor Group Holdings, Inc.24,450$7.93K0.00%+21,610+760.9%Added
Westshore Wealth, LLC20,000$6.42K0.00%00.0%Unchanged
Creative Planning18,609$5.97K0.00%00.0%Unchanged
Raymond James Financial Services Advisors, Inc.16,776$5.38K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)16,954$5.00K0.00%+3,450+25.5%Added
Williams Jones Wealth Management, LLC.15,000$4.81K0.00%00.0%Unchanged
Two Sigma Securities, LLC14,615$4.69K0.00%+14,615New
Victory Capital Management Inc12,519$4.02K0.00%−40.0%Reduced
Levin Capital Strategies, L.P.10,500$3.37K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.10,000$3.21K0.00%00.0%Unchanged
LMR Partners LLP10,000$3.21K0.00%−21,463−68.2%Reduced
Freestone Capital Holdings, LLC10,000$3.21K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA4,969$1.59K0.00%−1,300−20.7%Reduced
Federated Hermes, Inc.3,574$1.15K0.00%+1,154+47.7%Added
JPMorgan Chase & Co3,104$1.00K0.00%−4,704−60.2%Reduced
Wells Fargo & Company2,039$6550.00%+1,268+164.5%Added
Riggs Asset Managment Co. Inc.1,000$3210.00%00.0%Unchanged
Citigroup Inc1,046$3090.00%+174+20.0%Added
US Bancorp500$1610.00%00.0%Unchanged
Piscataqua Savings Bank500$1600.00%00.0%Unchanged
Meeder Asset Management Inc195$630.00%00.0%Unchanged
Albion Financial Group152$490.00%00.0%Unchanged
Lindbrook Capital, LLC86$280.00%00.0%Unchanged
Group One Trading, L.P.24$80.00%−2,598−99.1%Reduced
FMR LLC10$30.00%+10New
CoreCap Advisors, LLC5$20.00%+5New
Royal Bank of Canada643$00.00%−3,699−85.2%Reduced
Simplex Trading, LLC29$00.00%+29New
IFP Advisors, Inc29,501––−2,500−7.8%Reduced
OrbiMed Advisors LLC0$00.00%−1,882,768−100.0%Sold out
Fort Sheridan Advisors LLC0$00.00%−135,000−100.0%Sold out
Caliber Wealth Management, LLC0$00.00%−75,120−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−54,398−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−52,887−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−40,718−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−38,291−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−36,600−100.0%Sold out
Citadel Advisors LLC0$00.00%−27,454−100.0%Sold out
National Asset Management, Inc.0$00.00%−17,890−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−11,469−100.0%Sold out
Virtu Financial LLC0$00.00%−10,558−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−1,111−100.0%Sold out
ACT Capital Management, LLC––––Not filed
American Portfolios Advisors––––Not filed